Page 20 - Identifying and scaling AI startups for SDGs

Identifying and scaling AI startups for SDGs

launching emergent product lines, and developing client partnerships to elevate corporate
and brand identities.
• Emovo Care: Emovo develops accessible assistive devices to bring movement home for
people with motor impairments. Their first product is a portable orthosis that actively open
and close the hand for people with limited hand function. The core technology behind
the device is based on patent-protected artificial tendons.

Judges:

• Andreas Keibel; Business Development Manager, KUKA
• Betsy Mulé; Investor, F-Prime Capital
• Cyril Ebersweiler; General Partner, Founder and Venture Capitalist, SOSV
• Thomas Ryden; Executive Director, MassRobotics
• Ryan Wang; Co-Founder and General Partner, Outpost Capital

9 AI for Good Innovation Factory: 2023

9.1 Meet the Robotics for Good startups advancing sustainable
development – 1st session

Online, 7 November 2023

Moderators:
• Matt Oguz, Founding General Partner, Venture Science
• Guillem Martínez Roura, AI and Robotics Programme Officer, ITU
• Josh Choi, Director of Business Development, Korea Startup Forum

Startups:
• Wandercraft: Wandercraft, featured on The Robot Report, develops, manufactures and
markets autonomous walking exoskeletons. The first version, Atalante, was commercialized
in 2019 and is used by rehabilitation and neurology hospitals in Europe and the USA.
Atalante offers many patients innovative care based on realistic, hands-free multidirectional
locomotion. Read more here.
• Aquaai: Aquaai is a technology firm that believes everyone should have access to
environmental data. Hitting nine of the SDGs, Aquaai technology is 3-fold, data, a
software platform & a robot fish. Our unique bio-inspired fishlike AUV collects visual
and environmental data, which is delivered in real time to an online dashboard offering
customers an end-to-end solution called ‘FaaS’, fish-as-a-service.
• GiveMove: The Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE)
randomised clinical trial assesses the clinical impact and cost-effectiveness of genotypic
resistance testing of HIV to inform clinical management in HIV-positive children and
adolescents whose treatment is failing to control the virus. This research project will assess
if routine, early resistance testing yields a clinical benefit for children and adolescents
with HIV viraemia in resource-limited settings in Southern and East Africa (Lesotho and
Tanzania).
• Energy Robotics: Energy Robotics provides an end-to-end solution for autonomous
inspections in capital-intensive industries such as oil & gas, chemical, power and utilities.
Their hardware-agnostic software platform enables asset owners to easily manage a fleet
of robots and drones for autonomous inspection. They equip robots and drones to collect
high quality data and use AI driven analytics to convert it into actionable information.

12